{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T02:33:34Z","timestamp":1793759614681,"version":"4.6.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BDJ Open"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Oral lichen planus (OLP) is a chronic mucocutaneous autoimmune skin disease without a proper pathophysiology and approved therapy. As a result, several repurposed drugs have been used in clinical practice, and it remains unclear which one holds greater potential.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>The present study employs a network pharmacology to explore the disease biology and further investigate the target-specific binding efficacy of repurposed drugs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>\n                      Twenty-eight repurposed drug\u2019s (\n                      <jats:bold>D1<\/jats:bold>\n                      -\n                      <jats:bold>D28<\/jats:bold>\n                      ) efficacies against twelve targets were investigated using PyRx 0.8-AutoDock 4.2 software. Further, drug stability and reactivity were studied using molecular dynamics (MD) simulation at 200\u2009ns, Gibbs free energy, frontier molecular orbital theory, and structural activity relationship.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The above computational investigation suggested betamethasone (\n                      <jats:bold>D2<\/jats:bold>\n                      \/BETA) and triamcinolone acetonide (\n                      <jats:bold>D28<\/jats:bold>\n                      \/TACA) are two potential drugs, predominantly demonstrating higher binding efficacy against the glucocorticoid receptor (GR). Further, MD simulation, free-energy calculation revealed that\n                      <jats:bold>D28\/<\/jats:bold>\n                      TACA was comparatively more stable than\n                      <jats:bold>D2<\/jats:bold>\n                      \/BETA.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The network pharmacology explored possible drug targets for drug discovery and showed that\n                      <jats:bold>D28\/<\/jats:bold>\n                      TACA is a more effective treatment option among repurposed drugs.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41405-025-00384-y","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T16:52:53Z","timestamp":1766163173000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Target-specific therapeutic assessment of repurposed drug candidates for oral lichen planus: a network pharmacology-molecular dynamics simulation guided investigation"],"prefix":"10.1038","volume":"11","author":[{"given":"Alaka","family":"Sahoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasank Sekhar","family":"Swain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satya Ranjan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atala Bihari","family":"Jena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhir Kumar","family":"Paidesetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asim K.","family":"Duttaroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maitreyee","family":"Panda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"384_CR1","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.jfma.2018.01.021","volume":"117","author":"CP Chiang","year":"2018","unstructured":"Chiang CP, Yu-Fong Chang J, Wang YP, Wu YH, Lu SY, Sun A. Oral lichen planus\u2014differential diagnoses, serum autoantibodies, hematinic deficiencies, and management. J Formos Med Assoc. 2018;117:756\u201365.","journal-title":"J Formos Med Assoc"},{"key":"384_CR2","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1111\/odi.14127","volume":"29","author":"T De Porras-Carrique","year":"2023","unstructured":"De Porras-Carrique T, Ramos-Garc\u00eda P, Aguilar-Diosdado M, Warnakulasuriya S, Gonz\u00e1lez-Moles M\u00c1. Autoimmune disorders in oral lichen planus: a systematic review and meta-analysis. Oral Dis. 2023;29:1382\u201394.","journal-title":"Oral Dis"},{"key":"384_CR3","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/odi.13323","volume":"27","author":"M\u00c1 Gonz\u00e1lez-Moles","year":"2021","unstructured":"Gonz\u00e1lez-Moles M\u00c1, Warnakulasuriya S, Gonz\u00e1lez-Ruiz I, Gonz\u00e1lez-Ruiz L, Ay\u00e9n \u00c1, Lenouvel D, et al. Worldwide prevalence of oral lichen planus: A systematic review and meta-analysis. Oral Dis. 2021;27:813\u201328.","journal-title":"Oral Dis"},{"key":"384_CR4","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1001\/jamadermatol.2019.3797","volume":"156","author":"C Li","year":"2020","unstructured":"Li C, Tang X, Zheng X, Ge S, Wen H, Lin X, et al. Global prevalence and incidence estimates of oral lichen planus: a systematic review and meta-analysis. JAMA Dermatol. 2020;156:172\u201381.","journal-title":"JAMA Dermatol"},{"key":"384_CR5","unstructured":"Raj G, Raj M. Oral lichen planus. In: StatPearls [Internet], Treasure Island (FL): StatPearls Publishing; 2024."},{"key":"384_CR6","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1111\/odi.14142","volume":"29","author":"A El-Howati","year":"2023","unstructured":"El-Howati A, Thornhill MH, Colley HE, Murdoch C. Immune mechanisms in oral lichen planus. Oral Dis. 2023;29:1400\u201315. https:\/\/doi.org\/10.1111\/odi.14142.","journal-title":"Oral Dis"},{"key":"384_CR7","doi-asserted-by":"publisher","first-page":"E892","DOI":"10.1503\/cmaj.200309","volume":"192","author":"AF Hamour","year":"2020","unstructured":"Hamour AF, Klieb H, Eskander A. Oral lichen planus. CMAJ. 2020;192:E892 https:\/\/doi.org\/10.1503\/cmaj.200309.","journal-title":"CMAJ"},{"key":"384_CR8","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.18713.1","volume":"9","author":"E Shavit","year":"2020","unstructured":"Shavit E, Hagen K, Shear N. Oral lichen planus: a novel staging and algorithmic approach and all that is essential to know. F1000Res. 2020;9. F1000 Faculty Rev-206. https:\/\/doi.org\/10.12688\/f1000research.18713.1.","journal-title":"F1000Res"},{"key":"384_CR9","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3892\/etm.2020.9328","volume":"20","author":"D Rotaru","year":"2020","unstructured":"Rotaru D, Chisnoiu R, Picos AM, Picos A, Chisnoiu A. Treatment trends in oral lichen planus and oral lichenoid lesions (review). Exp Ther Med. 2020;20:198 https:\/\/doi.org\/10.3892\/etm.2020.9328.","journal-title":"Exp Ther Med"},{"key":"384_CR10","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1001\/jamadermatol.2022.0147","volume":"158","author":"R Balestri","year":"2022","unstructured":"Balestri R, Bortolotti R, Rech G, Girardelli CR, Zorzi MG, Magnano M. Treatment of oral erosive lichen planus with upadacitinib. JAMA Dermatol. 2022;158:457\u20138. https:\/\/doi.org\/10.1001\/jamadermatol.2022.0147.","journal-title":"JAMA Dermatol"},{"key":"384_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.997190","volume":"9","author":"D Didona","year":"2022","unstructured":"Didona D, Caposiena Caro RD, Sequeira Santos AM, Solimani F, Hertl M. Therapeutic strategies for oral lichen planus: state of the art and new insights. Front Med. 2022;9:997190. https:\/\/doi.org\/10.3389\/fmed.2022.997190.","journal-title":"Front Med"},{"key":"384_CR12","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1111\/odi.13704","volume":"27","author":"S Warnakulasuriya","year":"2021","unstructured":"Warnakulasuriya S, Kujan O, Aguirre-Urizar JM, Bagan JV, Gonz\u00e1lez-Moles M\u00c1, Kerr AR, et al. Oral potentially malignant disorders: a consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. Oral Dis. 2021;27:1862\u201380.","journal-title":"Oral Dis"},{"key":"384_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.5681\/joddd.2010.002","volume":"4","author":"M Boorghani","year":"2010","unstructured":"Boorghani M, Gholizadeh N, Taghavi Zenouz A, Vatankhah M, Mehdipour M. Oral lichen planus: clinical features, etiology, treatment and management; a review of literature. J Dent Res Dent Clin Dent Prospects. 2010;4:3\u20139. https:\/\/doi.org\/10.5681\/joddd.2010.002.","journal-title":"J Dent Res Dent Clin Dent Prospects"},{"key":"384_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.oooo.2016.03.011","volume":"122","author":"ZB Kurago","year":"2016","unstructured":"Kurago ZB. Etiology and pathogenesis of oral lichen planus: an overview. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;122:72\u201380.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"384_CR15","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s10123-021-00168-y","volume":"24","author":"TG Villa","year":"2021","unstructured":"Villa TG, S\u00e1nchez-P\u00e9rez \u00c1, Sieiro C. Oral lichen planus: a microbiologist point of view. Int Microbiol. 2021;24:275\u201389.","journal-title":"Int Microbiol"},{"key":"384_CR16","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.oraloncology.2017.03.012","volume":"68","author":"SMH Aghbari","year":"2017","unstructured":"Aghbari SMH, Abushouk AI, Attia A, Elmaraezy A, Menshawy A, Ahmed MS, et al. Malignant transformation of oral lichen planus and oral lichenoid lesions: a meta-analysis of 20095 patient data. Oral Oncol. 2017;68:92\u2013102. https:\/\/doi.org\/10.1016\/j.oraloncology.2017.03.012.","journal-title":"Oral Oncol"},{"key":"384_CR17","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1111\/odi.13812","volume":"27","author":"P Ramos-Garc\u00eda","year":"2021","unstructured":"Ramos-Garc\u00eda P, Gonz\u00e1lez-Moles M\u00c1, Warnakulasuriya S. Oral cancer development in lichen planus and related conditions-3.0 evidence level: a systematic review of systematic reviews. Oral Dis. 2021;27:1919\u201335. https:\/\/doi.org\/10.1111\/odi.13812.","journal-title":"Oral Dis"},{"key":"384_CR18","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.autrev.2015.06.005","volume":"14","author":"MB Mustafa","year":"2015","unstructured":"Mustafa MB, Porter SR, Smoller BR, Sitaru C. Oral mucosal manifestations of autoimmune skin diseases. Autoimmun Rev. 2015;14:930\u201351. https:\/\/doi.org\/10.1016\/j.autrev.2015.06.005.","journal-title":"Autoimmun Rev"},{"key":"384_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s40257-023-00814-3","volume":"25","author":"A Louisy","year":"2024","unstructured":"Louisy A, Humbert E, Samimi M. Oral lichen planus: an update on diagnosis and management. Am J Clin Dermatol. 2024;25:35\u201353. https:\/\/doi.org\/10.1007\/s40257-023-00814-3.","journal-title":"Am J Clin Dermatol"},{"key":"384_CR20","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.3390\/ijerph20021202","volume":"20","author":"G Serafini","year":"2023","unstructured":"Serafini G, De Biase A, Lamazza L, Mazzucchi G, Lollobrigida M. Efficacy of topical treatments for the management of symptomatic oral lichen planus: a systematic review. Int J Environ Res Public Health. 2023;20:1202 https:\/\/doi.org\/10.3390\/ijerph20021202.","journal-title":"Int J Environ Res Public Health"},{"key":"384_CR21","doi-asserted-by":"publisher","unstructured":"Lodi G, Manfredi M, Mercadante V, Murphy R, Carrozzo M. Interventions for treating oral lichen planus: corticosteroid therapies. Cochrane Database Syst Rev. 2020; CD001168. https:\/\/doi.org\/10.1002\/14651858.CD001168.pub3.","DOI":"10.1002\/14651858.CD001168.pub3"},{"key":"384_CR22","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1111\/bjd.17898","volume":"181","author":"SL Sun","year":"2019","unstructured":"Sun SL, Liu JJ, Zhong B, Wang JK, Jin X, Xu H, et al. Topical calcineurin inhibitors in the treatment of oral lichen planus: a systematic review and meta-analysis. Br J Dermatol. 2019;181:1166\u201376. https:\/\/doi.org\/10.1111\/bjd.17898.","journal-title":"Br J Dermatol"},{"key":"384_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.tripleo.2005.09.006","volume":"102","author":"PC Yoke","year":"2006","unstructured":"Yoke PC, Tin GB, Kim MJ, Rajaseharan A, Ahmed S, Thongprasom K, et al.Asian Lichen Planus Study Group A randomized controlled trial to compare steroid with cyclosporine for the topical treatment of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102:47\u201355. https:\/\/doi.org\/10.1016\/j.tripleo.2005.09.006.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"384_CR24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1601-0825.2012.01931.x","volume":"19","author":"ID O\u2019Neill","year":"2013","unstructured":"O\u2019Neill ID, Scully C. Biologics in oral medicine: ulcerative disorders. Oral Dis. 2013;19:37\u201345. https:\/\/doi.org\/10.1111\/j.1601-0825.2012.01931.x.","journal-title":"Oral Dis"},{"key":"384_CR25","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1600-0714.2011.01029.x","volume":"40","author":"J Zhang","year":"2011","unstructured":"Zhang J, Zhou G, Du GF, Xu XY, Zhou HM. Biologics, an alternative therapeutic approach for oral lichen planus. J Oral Pathol Med. 2011;40:521\u20134. https:\/\/doi.org\/10.1111\/j.1600-0714.2011.01029.x.","journal-title":"J Oral Pathol Med"},{"key":"384_CR26","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1111\/odi.13966","volume":"28","author":"M \u0141ukaszewska-Kuska","year":"2022","unstructured":"\u0141ukaszewska-Kuska M, \u015alebioda Z, Dorocka-Bobkowska B. The effectiveness of topical forms of dexamethasone in the treatment of oral lichen planus\u2014a systematic review. Oral Dis. 2022;28:2063\u201371. https:\/\/doi.org\/10.1111\/odi.13966.","journal-title":"Oral Dis"},{"key":"384_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.tripleo.2006.10.024","volume":"104","author":"A Jainkittivong","year":"2007","unstructured":"Jainkittivong A, Kuvatanasuchati J, Pipattanagovit P, Sinheng W. Candida in oral lichen planus patients undergoing topical steroid therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104:61\u20136. https:\/\/doi.org\/10.1016\/j.tripleo.2006.10.024.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"384_CR28","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s12906-020-03128-7","volume":"20","author":"SJ Kia","year":"2020","unstructured":"Kia SJ, Basirat M, Mortezaie T, Moosavi MS. Comparison of oral Nano-Curcumin with oral prednisolone on oral lichen planus: a randomized double-blinded clinical trial. BMC Complement Med Ther. 2020;20:328 https:\/\/doi.org\/10.1186\/s12906-020-03128-7.","journal-title":"BMC Complement Med Ther"},{"key":"384_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12903-022-02168-4","volume":"22","author":"S Sandhu","year":"2022","unstructured":"Sandhu S, Klein BA, Al-Hadlaq M, Chirravur P, Bajonaid A, Xu Y, et al. Oral lichen planus: comparative efficacy and treatment costs-a systematic review. BMC Oral Health. 2022;22:161. https:\/\/doi.org\/10.1186\/s12903-022-02168-4.","journal-title":"BMC Oral Health"},{"key":"384_CR30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.4103\/0973-029X.84474","volume":"15","author":"N Lavanya","year":"2011","unstructured":"Lavanya N, Jayanthi P, Rao UK, Ranganathan K. Oral lichen planus: an update on pathogenesis and treatment. J Oral Maxillofac Pathol. 2011;15:127\u201332. https:\/\/doi.org\/10.4103\/0973-029X.84474.","journal-title":"J Oral Maxillofac Pathol"},{"key":"384_CR31","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/dj11010026","volume":"11","author":"A Andabak-Rogulj","year":"2023","unstructured":"Andabak-Rogulj A, Vindi\u0161 E, Aleksijevi\u0107 LH, \u0160krinjar I, Juras DV, A\u0161\u010di\u0107 A, et al. Different treatment modalities of oral lichen planus\u2014a narrative review. Dent J. 2023;11:26 https:\/\/doi.org\/10.3390\/dj11010026.","journal-title":"Dent J"},{"key":"384_CR32","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3156785","volume":"2022","author":"H Ma","year":"2022","unstructured":"Ma H, Wang G, Guo X, Yao Y, Li C, Li X, et al. Network pharmacology and molecular docking analysis explores the mechanisms of Cordyceps sinensis in the treatment of oral lichen planus. J Oncol. 2022;2022:3156785. https:\/\/doi.org\/10.1155\/2022\/3156785.","journal-title":"J Oncol"},{"key":"384_CR33","doi-asserted-by":"publisher","first-page":"e39352","DOI":"10.1097\/MD.0000000000039352","volume":"103","author":"W Chang","year":"2024","unstructured":"Chang W, Shi J, Li L, Zhang P, Ren Y, Yan Y, et al. Network pharmacology and molecular docking analysis predict the mechanisms of Huangbai liniment in treating oral lichen planus. Medicines. 2024;103:e39352 https:\/\/doi.org\/10.1097\/MD.0000000000039352.","journal-title":"Medicines"},{"key":"384_CR34","doi-asserted-by":"publisher","first-page":"138638","DOI":"10.1016\/J.MOLSTRUC.2024.138638","volume":"1313","author":"M Patel","year":"2024","unstructured":"Patel M, Al-Keridis LA, Alomrani SO, Alshammari N, Ibrahim AMM, Adnan M. Antioxidant effects and potential molecular mechanism of action of Diplocyclos palmatus (L.) C. Jeffrey fruits based on systematic network pharmacology with experimental validation. J Mol Struct. 2024;1313:138638 https:\/\/doi.org\/10.1016\/J.MOLSTRUC.2024.138638.","journal-title":"J Mol Struct"},{"key":"384_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.138698","volume":"1314","author":"B Xu","year":"2024","unstructured":"Xu B, Sun G, Zhang Y. Integrated bioinformatics, network pharmacology, molecular docking, and molecular dynamics simulation to explore the potential pharmacological mechanism of Erigeron breviscapus (Vant.) Hand-Mazz regulating ferroptosis for the treatment of Alzheimer\u2019s disease. J Mol Struct. 2024;1314:138698. https:\/\/doi.org\/10.1016\/j.molstruc.2024.138698.","journal-title":"J Mol Struct"},{"key":"384_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.967281","volume":"13","author":"R Wang","year":"2022","unstructured":"Wang R, Zhang X, Wang S. Differential genotypes of TNF-\u03b1 and IL-10 for immunological diagnosis in discoid lupus erythematosus and oral lichen planus: a narrative review. Front Immunol. 2022;13:967281. https:\/\/doi.org\/10.3389\/fimmu.2022.967281.","journal-title":"Front Immunol"},{"key":"384_CR37","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jdcr.2023.05.013","volume":"37","author":"P Kim-Lim","year":"2023","unstructured":"Kim-Lim P, Thomas C. Crushed apremilast for the treatment of oral lichen planus. JAAD Case Rep. 2023;37:114\u20135. https:\/\/doi.org\/10.1016\/j.jdcr.2023.05.013.","journal-title":"JAAD Case Rep"},{"key":"384_CR38","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M, et al. NF-\u03baB in biology and targeted therapy: new insights and translational implications. Signal Transduct Target Ther. 2024;9:53 https:\/\/doi.org\/10.1038\/s41392-024-01757-9.","journal-title":"Signal Transduct Target Ther"},{"key":"384_CR39","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1684\/ejd.2015.2691","volume":"26","author":"ME Kubin","year":"2016","unstructured":"Kubin ME, H\u00e4gg PM, Kokkonen N, V\u00e4yrynen JP, Haapasaari KM, Moilanen J, et al. Glucocorticoid receptors GR\u03b1 and GR\u03b2 are expressed in inflammatory dermatoses. Eur J Dermatol. 2016;26:21\u20137.","journal-title":"Eur J Dermatol"},{"key":"384_CR40","doi-asserted-by":"publisher","first-page":"591","DOI":"10.4103\/ijd.ijd_1060_20","volume":"66","author":"N Mohtasham","year":"2021","unstructured":"Mohtasham N, Shahabinejad M, Kafiroudi S, Mohajertehran F. Evaluation of the altered tissue expression of HSP60 and HSP70 genes in oral and cutaneous lichen planus compared to normal healthy tissues. Indian J Dermatol. 2021;66:591\u20137. https:\/\/doi.org\/10.4103\/ijd.ijd_1060_20.","journal-title":"Indian J Dermatol"},{"key":"384_CR41","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.job.2020.05.003","volume":"62","author":"YA Osorio-Osorno","year":"2020","unstructured":"Osorio-Osorno YA, Parada-Sanchez MT, Arango JC, Arboleda D. Toro oral lichen planus: a chronic inflammatory model to study the regulation of the Toll-like receptor signaling in oral keratinocytes. J Oral Biosci. 2020;62:115\u201322. https:\/\/doi.org\/10.1016\/j.job.2020.05.003.","journal-title":"J Oral Biosci"},{"key":"384_CR42","doi-asserted-by":"publisher","first-page":"992","DOI":"10.3390\/molecules21080992","volume":"21","author":"L Garc\u00eda-Pupo","year":"2016","unstructured":"Garc\u00eda-Pupo L, Zaldo-Castro A, Exarchou V, Tacoronte-Morales JE, Pieters L, Vanden Berghe W, et al. In vitro neuroprotective and anti-inflammatory activities of natural and semi-synthetic spirosteroid analogues. Molecules. 2016;21:992 https:\/\/doi.org\/10.3390\/molecules21080992.","journal-title":"Molecules"},{"key":"384_CR43","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.archoralbio.2017.02.013","volume":"78","author":"C Gong","year":"2017","unstructured":"Gong C, Sun S, Liu B, Wang J, Chen X. Identification of potential therapeutic target genes, key miRNAs and mechanisms in oral lichen planus by bioinformatics analysis. Arch Oral Biol. 2017;78:122\u20138.","journal-title":"Arch Oral Biol"},{"key":"384_CR44","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/jop.13100","volume":"49","author":"P Ramakrishnan","year":"2020","unstructured":"Ramakrishnan P, Pavan Kumar T, Saraswathy GR, Sujatha S. In silico evaluation of drugs used in treatment of oral lichen planus. J Oral Pathol Med. 2020;49:926\u201332. https:\/\/doi.org\/10.1111\/jop.13100.","journal-title":"J Oral Pathol Med"},{"key":"384_CR45","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s40257-023-00814-3","volume":"25","author":"A Louisy","year":"2024","unstructured":"Louisy A, Humbert E, Samimi M. Oral Lichen Planus: an update on diagnosis and management. Am J Clin Dermatol. 2024;25:35\u201353.","journal-title":"Am J Clin Dermatol"},{"key":"384_CR46","doi-asserted-by":"publisher","unstructured":"Swain SS, Sahoo A, Singh SR, Sahoo J, Paidesetty SK. Synthesis, spectroscopic analysis, and computational-based investigations on \u2018azo-coumarin-Co(II)-galangin\u2019 hybrids exhibit multipotential activities. J Biomol Struct Dyn. 2024;1\u201312. https:\/\/doi.org\/10.1080\/07391102.2024.2326666.","DOI":"10.1080\/07391102.2024.2326666"},{"key":"384_CR47","doi-asserted-by":"publisher","first-page":"4763","DOI":"10.1080\/14786419.2021.2008387","volume":"36","author":"SS Swain","year":"2022","unstructured":"Swain SS, Rout SS, Sahoo A, Oyedemi SO, Hussain T. Antituberculosis, antioxidant and cytotoxicity profiles of quercetin: a systematic and cost-effective in silico and in vitro approach. Nat Prod Res. 2022;36:4763\u20137.","journal-title":"Nat Prod Res"},{"key":"384_CR48","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1002\/prot.26341","volume":"90","author":"SS Swain","year":"2022","unstructured":"Swain SS, Singh SR, Sahoo A, Panda PK, Hussain T, Pati S. Integrated bioinformatics-cheminformatics approach toward locating pseudo-potential antiviral marine alkaloids against SARS-CoV-2-Mpro. Proteins. 2022;90:1617\u201333. https:\/\/doi.org\/10.1002\/prot.26341.","journal-title":"Proteins"},{"key":"384_CR49","doi-asserted-by":"publisher","first-page":"6463","DOI":"10.1080\/07391102.2021.1885495","volume":"40","author":"SS Swain","year":"2022","unstructured":"Swain SS, Singh SR, Sahoo A, Hussain T, Pati S. Anti-HIV-drug and phyto-flavonoid combination against SARS-CoV-2: a molecular docking-simulation base assessment. J Biomol Struct Dyn. 2022;40:6463\u201376. https:\/\/doi.org\/10.1080\/07391102.2021.1885495.","journal-title":"J Biomol Struct Dyn"},{"key":"384_CR50","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.3390\/biomedicines9111505","volume":"9","author":"A Sahoo","year":"2021","unstructured":"Sahoo A, Fuloria S, Swain SS, Panda SK, Sekar M, Subramaniyan V, et al. Potential of marine terpenoids against SARS-CoV-2: an in silico drug development approach. Biomedicines. 2021;9:1505 https:\/\/doi.org\/10.3390\/biomedicines9111505.","journal-title":"Biomedicines"},{"key":"384_CR51","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1208\/s12248-015-9737-5","volume":"17","author":"Y Hu","year":"2015","unstructured":"Hu Y, Bajorath J. Structural and activity profile relationships between drug scaffolds. AAPS J. 2015;17:609\u201319. https:\/\/doi.org\/10.1208\/s12248-015-9737-5. Epub 2015 Feb 20.","journal-title":"AAPS J"},{"key":"384_CR52","doi-asserted-by":"publisher","first-page":"13259","DOI":"10.3390\/ijms222413259","volume":"22","author":"MA Ejalonibu","year":"2021","unstructured":"Ejalonibu MA, Ogundare SA, Elrashedy AA, Ejalonibu MA, Lawal MM, Mhlongo NN, et al. Drug discovery for Mycobacterium tuberculosis using structure-based computer-aided drug design approach. Int J Mol Sci. 2021;22:13259 https:\/\/doi.org\/10.3390\/ijms222413259.","journal-title":"Int J Mol Sci"},{"key":"384_CR53","doi-asserted-by":"crossref","unstructured":"Vald\u00e9s-Tresanco MS, Vald\u00e9s-Tresanco ME, Valiente PA, Moreno E. gmx_MMPBSA: A new tool to perform end-state free energy calculations with GROMACS. J Chem Theory Comput. 2021;17:6281\u201391. https:\/\/pubs.acs.org\/doi\/10.1021\/acs.jctc.1c00645.","DOI":"10.1021\/acs.jctc.1c00645"},{"key":"384_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114173","volume":"232","author":"SS Swain","year":"2022","unstructured":"Swain SS, Pati S, Hussain T. Quinoline heterocyclic containing plant and marine candidates against drug-resistant Mycobacterium tuberculosis: a systematic drug-ability investigation. Eur J Med Chem. 2022;232:114173. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114173.","journal-title":"Eur J Med Chem"},{"key":"384_CR55","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.steroids.2012.08.019","volume":"77","author":"A Midzak","year":"2012","unstructured":"Midzak A, Rammouz G, Papadopoulos V. Structure-activity relationship (SAR) analysis of a family of steroids acutely controlling steroidogenesis. Steroids. 2012;77:1327\u201334.","journal-title":"Steroids"},{"key":"384_CR56","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.1021\/jm300317k","volume":"55","author":"NM Hamilton","year":"2012","unstructured":"Hamilton NM, Dawson M, Fairweather EE, Hamilton NS, Hitchin JR, James DI, et al. Novel steroid inhibitors of glucose 6-phosphate dehydrogenase. J Med Chem. 2012;55:4431\u201345.","journal-title":"J Med Chem"},{"key":"384_CR57","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41435-021-00139-3","volume":"22","author":"S Chakraborty","year":"2021","unstructured":"Chakraborty S, Pramanik J, Mahata B. Revisiting steroidogenesis and its role in immune regulation with the advanced tools and technologies. Genes Immun. 2021;22:125\u201340.","journal-title":"Genes Immun"},{"key":"384_CR58","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/j.apsb.2020.10.012","volume":"11","author":"N Das","year":"2021","unstructured":"Das N, Mishra SK, Bishayee A, Ali ES, Bishayee A. The phytochemical, biological, and medicinal attributes of phytoecdysteroids: an updated review. Acta Pharm Sin B. 2021;11:1740\u201366.","journal-title":"Acta Pharm Sin B"},{"key":"384_CR59","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s13659-022-00345-0","volume":"12","author":"ML Xiang","year":"2022","unstructured":"Xiang ML, Hu BY, Qi ZH, Wang XN, Xie TZ, Wang ZJ, et al. Chemistry and bioactivities of natural steroidal alkaloids. Nat Prod Bioprospect. 2022;12:23 https:\/\/doi.org\/10.1007\/s13659-022-00345-0.","journal-title":"Nat Prod Bioprospect"},{"key":"384_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s12903-023-03385-1","volume":"23","author":"AJ Murugan","year":"2023","unstructured":"Murugan AJ, Ganesan A, Aniyan YK, Lakshmi KC, Asokan K. Comparison of topical purslane & topical 0.1% triamcinolone acetonide in the management of oral lichen planus\u2014a double-blinded clinical trial. BMC Oral Health. 2023;23:678. https:\/\/doi.org\/10.1186\/s12903-023-03385-1.","journal-title":"BMC Oral Health"},{"key":"384_CR61","doi-asserted-by":"publisher","first-page":"236","DOI":"10.4103\/ccd.ccd_899_20","volume":"13","author":"C Walia","year":"2022","unstructured":"Walia C, Rallan NS, Premkumar A, Roy S. Clinical evaluation of efficacy of triamcinolone acetonide with tacrolimus in the management of oral lichen planus: a pilot prospective observational study. Contemp Clin Dent. 2022;13:236\u201341. https:\/\/doi.org\/10.4103\/ccd.ccd_899_20.","journal-title":"Contemp Clin Dent"},{"key":"384_CR62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001168.pub3","volume":"2","author":"G Lodi","year":"2020","unstructured":"Lodi G, Manfredi M, Mercadante V, Murphy R, Carrozzo M. Interventions for treating oral lichen planus: corticosteroid therapies. Cochrane Database Syst Rev. 2020;2:CD001168. https:\/\/doi.org\/10.1002\/14651858.CD001168.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"384_CR63","doi-asserted-by":"publisher","first-page":"4323","DOI":"10.1007\/s00784-023-05051-w","volume":"27","author":"Q Zeng","year":"2023","unstructured":"Zeng Q, Liu Y, Wang S, Wang H, Yu S, Wu F, et al. Significant efficacy of short-course, low-concentration betamethasone mouthwash therapy for severe erosive oral lichen planus: a randomized controlled trial. Clin Oral Investig. 2023;27:4323\u201334. https:\/\/doi.org\/10.1007\/s00784-023-05051-w.","journal-title":"Clin Oral Investig"},{"key":"384_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2023.100413","volume":"3","author":"BA Badwan","year":"2023","unstructured":"Badwan BA, Liaropoulos G, Kyrodimos E, Skaltsas D, Tsirigos A, Gorgoulis VG. Machine learning approaches to predict drug efficacy and toxicity in oncology. Cell Rep Methods. 2023;3:100413. https:\/\/doi.org\/10.1016\/j.crmeth.2023.100413.","journal-title":"Cell Rep Methods"},{"key":"384_CR65","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.3390\/medicina59081448","volume":"59","author":"W Huang","year":"2023","unstructured":"Huang W, Huang X, Yang L, Han W, Zhu Z, Wang Y, et al. Network pharmacology and molecular docking analysis exploring the mechanism of Tripterygium wilfordii in the treatment of oral lichen planus. Medicines. 2023;59:1448 https:\/\/doi.org\/10.3390\/medicina59081448.","journal-title":"Medicines"},{"key":"384_CR66","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1055\/s-0042-1760300","volume":"17","author":"P Achararit","year":"2023","unstructured":"Achararit P, Manaspon C, Jongwannasiri C, Phattarataratip E, Osathanon T, Sappayatosok K. Artificial intelligence-based diagnosis of oral lichen planus using deep convolutional neural networks. Eur J Dent. 2023;17:1275\u201382. https:\/\/doi.org\/10.1055\/s-0042-1760300.","journal-title":"Eur J Dent"},{"key":"384_CR67","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.3892\/or.2017.5487","volume":"37","author":"Q Yang","year":"2017","unstructured":"Yang Q, Guo B, Sun H, Zhang J, Liu S, Hexige S, et al. Identification of the key genes implicated in the transformation of OLP to OSCC using RNA-sequencing. Oncol Rep. 2017;37:2355\u201365. https:\/\/doi.org\/10.3892\/or.2017.5487.","journal-title":"Oncol Rep"},{"key":"384_CR68","first-page":"127","volume":"8","author":"U Soni","year":"2022","unstructured":"Soni U, Singh P, Gupta OP, Gupta S, Singh SP, Singh P, et al. Lichen planus drugs re-purposing as potential anti COVID-19 therapeutics through molecular docking and molecular dynamics simulation approach. J Clin Transl Res. 2022;8:127\u201346.","journal-title":"J Clin Transl Res"},{"key":"384_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s41065-021-00202-z","volume":"158","author":"H Wang","year":"2021","unstructured":"Wang H, Deng Y, Peng S, Yan L, Xu H, Wang Q, et al. RNA-Seq-based transcriptome analysis in oral lichen planus. Hereditas. 2021;158:39. https:\/\/doi.org\/10.1186\/s41065-021-00202-z.","journal-title":"Hereditas"},{"key":"384_CR70","doi-asserted-by":"publisher","first-page":"e0257356","DOI":"10.1371\/journal.pone.0257356","volume":"16","author":"PT Vo","year":"2021","unstructured":"Vo PT, Choi SS, Park HR, Lee A, Jeong SH, Choi Y. Gene signatures associated with barrier dysfunction and infection in oral lichen planus identified by analysis of transcriptomic data. PLoS One. 2021;16:e0257356 https:\/\/doi.org\/10.1371\/journal.pone.0257356.","journal-title":"PLoS One"},{"key":"384_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-04769-z","volume":"12","author":"Z Zhao","year":"2022","unstructured":"Zhao Z, Wang L, Zhang M, Zhou C, Wang Y, Ma J, et al. Reveals of quercetin\u2019s therapeutic effects on oral lichen planus based on network pharmacology approach and experimental validation. Sci Rep. 2022;12:1162. https:\/\/doi.org\/10.1038\/s41598-022-04769-z.","journal-title":"Sci Rep"},{"key":"384_CR72","doi-asserted-by":"publisher","unstructured":"Acharya T, Nanda A, Swain SS. Exploration of bioactive compounds in Benincasa hispida seeds: Insight into their therapeutic potential for Alzheimer's disease management using computer-aided drug design platform. Chem Biodivers. 2025;22:e202403374. https:\/\/doi.org\/10.1002\/cbdv.202403374.","DOI":"10.1002\/cbdv.202403374"},{"key":"384_CR73","doi-asserted-by":"publisher","unstructured":"Sousa C, Sahoo A, Swain SS, Gupta P, Silva F, Azevedo AS, et al. In silico and in vitro potential antifungal insights of insectderived peptides in the management of Candida sp. infections. Int J Mol Sci. 2025; 26:7449. https:\/\/doi.org\/10.3390\/ijms26157449.","DOI":"10.3390\/ijms26157449"},{"key":"384_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115591","volume":"298","author":"A Sahoo","year":"2022","unstructured":"Sahoo A, Jena AK, Panda M. Experimental and clinical trial investigations of phyto-extracts, phyto-chemicals and phyto-formulations against oral lichen planus: a systematic review. J Ethnopharmacol. 2022;298:115591. https:\/\/doi.org\/10.1016\/j.jep.2022.115591.","journal-title":"J Ethnopharmacol"}],"container-title":["BDJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41405-025-00384-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41405-025-00384-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41405-025-00384-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T08:53:30Z","timestamp":1768899210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41405-025-00384-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["384"],"URL":"https:\/\/doi.org\/10.1038\/s41405-025-00384-y","relation":{},"ISSN":["2056-807X"],"issn-type":[{"value":"2056-807X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In this article the affiliation details for Shasank Sekhar Swain were incorrectly given as \u2018Department of Bioinformatics, Pondicherry University, Puducherry, India\u2019 but should have been \u2018BRIC-Institute of Life Sciences Bioincubator, Bhubaneswar, Odisha, India\u2019. The original article has been corrected.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study is entirely based on in silico analyses and does not involve human participants, human data, or any personal patient information. Therefore, consent to participate is not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"99"}}